These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1339650)

  • 1. Activation of immune system effector function by T-cell or Fc receptor intracellular domains.
    Romeo C; Kolanus W; Amiot M; Seed B
    Cold Spring Harb Symp Quant Biol; 1992; 57():117-25. PubMed ID: 1339650
    [No Abstract]   [Full Text] [Related]  

  • 2. Safer CARS.
    Heslop HE
    Mol Ther; 2010 Apr; 18(4):661-2. PubMed ID: 20357776
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain.
    Romeo C; Amiot M; Seed B
    Cell; 1992 Mar; 68(5):889-97. PubMed ID: 1547489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it safer CARs that we need, or safer rules of the road?
    Junghans RP
    Mol Ther; 2010 Oct; 18(10):1742-3. PubMed ID: 20885432
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides.
    Romeo C; Seed B
    Cell; 1991 Mar; 64(5):1037-46. PubMed ID: 1900456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.
    Stancovski I; Schindler DG; Waks T; Yarden Y; Sela M; Eshhar Z
    J Immunol; 1993 Dec; 151(11):6577-82. PubMed ID: 7902379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.
    Roberts MR; Cooke KS; Tran AC; Smith KA; Lin WY; Wang M; Dull TJ; Farson D; Zsebo KM; Finer MH
    J Immunol; 1998 Jul; 161(1):375-84. PubMed ID: 9647246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells.
    Hombach A; Schneider C; Sent D; Koch D; Willemsen RA; Diehl V; Kruis W; Bolhuis RL; Pohl C; Abken H
    Int J Cancer; 2000 Oct; 88(1):115-20. PubMed ID: 10962448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte Fc receptors: the special case of T cells.
    Sandor M; Lynch RG
    Immunol Today; 1993 May; 14(5):227-31. PubMed ID: 8517922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TCR zeta-chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes.
    Geiger TL; Leitenberg D; Flavell RA
    J Immunol; 1999 May; 162(10):5931-9. PubMed ID: 10229830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein.
    Berney C; Herren S; Power CA; Gordon S; Martinez-Pomares L; Kosco-Vilbois MH
    J Exp Med; 1999 Sep; 190(6):851-60. PubMed ID: 10499923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.
    Haga CL; Ehrhardt GR; Boohaker RJ; Davis RS; Cooper MD
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9770-5. PubMed ID: 17522256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of Fc receptors of lymphocytes, macrophages and other mammalian cells in immune processes].
    Liampert IM
    Usp Sovrem Biol; 1982; 94(1):67-82. PubMed ID: 6753399
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
    Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
    Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile strategy for controlling the specificity and activity of engineered T cells.
    Ma JS; Kim JY; Kazane SA; Choi SH; Yun HY; Kim MS; Rodgers DT; Pugh HM; Singer O; Sun SB; Fonslow BR; Kochenderfer JN; Wright TM; Schultz PG; Young TS; Kim CH; Cao Y
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):E450-8. PubMed ID: 26759368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes.
    Amigorena S; Bonnerot C; Drake JR; Choquet D; Hunziker W; Guillet JG; Webster P; Sautes C; Mellman I; Fridman WH
    Science; 1992 Jun; 256(5065):1808-12. PubMed ID: 1535455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.
    Ellebrecht CT; Bhoj VG; Nace A; Choi EJ; Mao X; Cho MJ; Di Zenzo G; Lanzavecchia A; Seykora JT; Cotsarelis G; Milone MC; Payne AS
    Science; 2016 Jul; 353(6295):179-84. PubMed ID: 27365313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the lymphocytic receptor binding immunoglobulin G Fc fragment].
    Nowak J
    Postepy Hig Med Dosw; 1981; 35(2):129-58. PubMed ID: 7038649
    [No Abstract]   [Full Text] [Related]  

  • 20. Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma.
    Haynes NM; Snook MB; Trapani JA; Cerruti L; Jane SM; Smyth MJ; Darcy PK
    J Immunol; 2001 Jan; 166(1):182-7. PubMed ID: 11123291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.